Found: 46
Select item for more details and to access through your institution.
Postradical prostatectomy prostate‐specific antigen outcomes after 6 versus 18 months of perioperative androgen‐deprivation therapy in men with localized, unfavorable intermediate‐risk or high‐risk prostate cancer: Results of part 2 of a randomized phase 2 trial
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 9, p. 1629, doi. 10.1002/cncr.35170
- By:
- Publication type:
- Article
Adjuvant and salvage radiotherapy after neoadjuvant therapy and radical prostatectomy for high‐risk localized prostate cancer.
- Published in:
- Prostate, 2024, v. 84, n. 4, p. 342, doi. 10.1002/pros.24653
- By:
- Publication type:
- Article
Molecular features of prostate cancer after neoadjuvant therapy in the phase 3 CALGB 90203 trial.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 1, p. 115, doi. 10.1093/jnci/djad184
- By:
- Publication type:
- Article
SNMMI Consensus Statement on Patient Selection and Appropriate Use of <sup>177</sup>Lu-PSMA-617 Radionuclide Therapy.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 9, p. 1417, doi. 10.2967/jnumed.123.265952
- By:
- Publication type:
- Article
Clinical Implementation of <sup>177</sup>Lu-PSMA-617 in the United States: Lessons Learned and Ongoing Challenges.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 3, p. 349, doi. 10.2967/jnumed.122.265194
- By:
- Publication type:
- Article
Gaining metabolic insight in older men undergoing androgen deprivation therapy for prostate cancer (the ADT & Metabolism Study): Protocol of a longitudinal, observational, cohort study.
- Published in:
- PLoS ONE, 2023, v. 16, n. 2, p. 1, doi. 10.1371/journal.pone.0281508
- By:
- Publication type:
- Article
Neoadjuvant Novel Hormonal Therapy Followed by Prostatectomy versus Up-Front Prostatectomy for High-Risk Prostate Cancer: A Comparative Analysis.
- Published in:
- AUANews, 2022, v. 27, p. 16
- By:
- Publication type:
- Article
Genetic testing in prostate cancer management: Considerations informing primary care.
- Published in:
- CA: A Cancer Journal for Clinicians, 2022, v. 72, n. 4, p. 360, doi. 10.3322/caac.21720
- By:
- Publication type:
- Article
Association of B7‐H3 expression with racial ancestry, immune cell density, and androgen receptor activation in prostate cancer.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 12, p. 2269, doi. 10.1002/cncr.34190
- By:
- Publication type:
- Article
Implementation of a prostate cancer‐specific targeted sequencing panel for credentialing of patient‐derived cell lines and genomic characterization of patient samples.
- Published in:
- Prostate, 2022, v. 82, n. 5, p. 584, doi. 10.1002/pros.24305
- By:
- Publication type:
- Article
The Impact of COVID-19 on Clinical Trial Execution at the Dana-Farber Cancer Institute.
- Published in:
- 2021
- By:
- Publication type:
- Journal Article
Circulating Cell-Free DNA as Biomarker of Taxane Resistance in Metastatic Castration-Resistant Prostate Cancer.
- Published in:
- Cancers, 2021, v. 13, n. 16, p. 4055, doi. 10.3390/cancers13164055
- By:
- Publication type:
- Article
Neoadjuvant Intense ADT prior to Radical Prostatectomy: Steps toward a Shift in Paradigm.
- Published in:
- AUANews, 2021, v. 26, n. 8, p. 22
- By:
- Publication type:
- Article
Methylation of SRD5A2 promoter predicts a better outcome for castration-resistant prostate cancer patients undergoing androgen deprivation therapy.
- Published in:
- PLoS ONE, 2020, v. 14, n. 3, p. 1, doi. 10.1371/journal.pone.0229754
- By:
- Publication type:
- Article
Evaluating a Video-Based, Personalized Webpage in Genitourinary Oncology Clinical Trials: A Phase 2 Randomized Trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
A phase 2 trial of abiraterone acetate without glucocorticoids for men with metastatic castration-resistant prostate cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Prostate Cancer-Specific Mortality Across Gleason Scores in Black vs Nonblack Men.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A dose finding clinical trial of cabozantinib (XL184) administered in combination with abiraterone acetate in metastatic castration‐resistant prostate cancer.
- Published in:
- Prostate, 2018, v. 78, n. 14, p. 1053, doi. 10.1002/pros.23662
- By:
- Publication type:
- Article
Time of metastatic disease presentation and volume of disease are prognostic for metastatic hormone sensitive prostate cancer (mHSPC).
- Published in:
- Prostate, 2018, v. 78, n. 12, p. 889, doi. 10.1002/pros.23645
- By:
- Publication type:
- Article
The impact of statin use on the efficacy of abiraterone acetate in patients with castration-resistant prostate cancer.
- Published in:
- Prostate, 2017, v. 77, n. 13, p. 1303, doi. 10.1002/pros.23390
- By:
- Publication type:
- Article
Aberrant corticosteroid metabolism in tumor cells enables GR takeover in enzalutamide resistant prostate cancer.
- Published in:
- eLife, 2017, p. 1, doi. 10.7554/eLife.20183
- By:
- Publication type:
- Article
Prostate cancer: Developing novel approaches to castration-sensitive disease.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Association of tumour microRNA profiling with outcomes in patients with advanced urothelial carcinoma receiving first-line platinum-based chemotherapy.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Detecting metastatic prostate carcinoma in pelvic lymph nodes following neoadjuvant hormone therapy: the eyes have it!
- Published in:
- Histopathology, 2016, v. 68, n. 2, p. 303, doi. 10.1111/his.12739
- By:
- Publication type:
- Article
Docetaxel, bevacizumab, and androgen deprivation therapy for biochemical disease recurrence after definitive local therapy for prostate cancer.
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
Somatic Copy Number Abnormalities and Mutations in PI3K/AKT/mTOR Pathway Have Prognostic Significance for Overall Survival in Platinum Treated Locally Advanced or Metastatic Urothelial Tumors.
- Published in:
- PLoS ONE, 2015, v. 10, n. 6, p. 1, doi. 10.1371/journal.pone.0124711
- By:
- Publication type:
- Article
Castration-Resistant Prostate Cancer Bone Metastasis Response Measured by <sup>18</sup>F-Fluoride PET After Treatment with Dasatinib and Correlation with Progression-Free Survival: Results from American College of Radiology Imaging Network 6687.
- Published in:
- Journal of Nuclear Medicine, 2015, v. 56, n. 3, p. 354, doi. 10.2967/jnumed.114.146936
- By:
- Publication type:
- Article
Functional analysis of single cells identifies a rare subset of circulating tumor cells with malignant traits.
- Published in:
- Integrative Biology, 2014, v. 6, n. 4, p. 388, doi. 10.1039/c3ib40264a
- By:
- Publication type:
- Article
Neoadjuvant Therapy.
- Published in:
- Oncologist, 2013, v. 18, p. S6
- By:
- Publication type:
- Article
Rationale for and Review of Neoadjuvant Therapy Prior to Radical Prostatectomy for Patients with High-Risk Prostate Cancer.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Clinical predictors of survival in men with castration-resistant prostate cancer.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 16, p. 2990, doi. 10.1002/cncr.28102
- By:
- Publication type:
- Article
Clinical predictors of survival in men with castration-resistant prostate cancer: evidence that Gleason score 6 cancer can evolve to lethal disease.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Abiraterone Acetate: Targeting Persistent Androgen Dependence in Castration-Resistant Prostate Cancer.
- Published in:
- Advances in Therapy, 2013, v. 30, n. 8, p. 727, doi. 10.1007/s12325-013-0050-3
- By:
- Publication type:
- Article
Secondary Hormone Therapy for Castration-Resistant Prostate Cancer.
- Published in:
- Oncology (08909091), 2013, v. 27, n. 5, p. 1
- By:
- Publication type:
- Article
Phase II trial of RAD001 and bicalutamide for castration-resistant prostate cancer.
- Published in:
- BJU International, 2012, v. 110, n. 11, p. 1729, doi. 10.1111/j.1464-410X.2012.11456.x
- By:
- Publication type:
- Article
Activity of ketoconazole after taxane-based chemotherapy in castration-resistant prostate cancer.
- Published in:
- BJU International, 2010, v. 105, n. 10, p. 1392, doi. 10.1111/j.1464-410X.2009.08971.x
- By:
- Publication type:
- Article
Activity of Dutasteride Plus Ketoconazole in Castration-Refractory Prostate Cancer After Progression on Ketoconazole Alone.
- Published in:
- Clinical Genitourinary Cancer, 2009, v. 7, n. 3, p. E90, doi. 10.3816/CGC.2009.n.030
- By:
- Publication type:
- Article
Abiraterone--Where Do We Stand?
- Published in:
- AUANews, 2009, v. 14, n. 4, p. 12
- By:
- Publication type:
- Article
Time to Prostate-Specific Antigen Nadir Independently Predicts Overall Survival in Patients Who Have Metastatic Hormone-Sensitive Prostate Cancer Treated With Androgen-Deprivation Therapy.
- Published in:
- Cancer (0008543X), 2009, v. 115, n. 5, p. 981, doi. 10.1002/cncr.24064
- By:
- Publication type:
- Article
A phase II study of mifepristone (RU-486) in castration-resistant prostate cancer, with a correlative assessment of androgen-related hormones.
- Published in:
- BJU International, 2008, v. 101, n. 9, p. 1084, doi. 10.1111/j.1464-410X.2008.07509.x
- By:
- Publication type:
- Article
Efficacy of Androgen Deprivation Therapy (ADT) in Patients With Advanced Prostate Cancer.
- Published in:
- Cancer (0008543X), 2008, v. 112, n. 6, p. 1247, doi. 10.1002/cncr.23304
- By:
- Publication type:
- Article
Response to docetaxel/carboplatin-based chemotherapy as first- and second-line therapy in patients with metastatic hormone-refractory prostate cancer.
- Published in:
- BJU International, 2008, v. 101, n. 3, p. 308, doi. 10.1111/j.1464-410X.2007.07331.x
- By:
- Publication type:
- Article
A Phase 2 Study of Carboplatin Plus Docetaxel in Men With Metastatic Hormone-refractory Prostate Cancer Who Are Refractory to Docetaxel.
- Published in:
- Cancer (0008543X), 2008, v. 112, n. 3, p. 521, doi. 10.1002/cncr.23195
- By:
- Publication type:
- Article
Evaluation of Prostate-Specific Antigen Declines for Surrogacy in Patients Treated on SWOG 99-16.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2006, v. 98, n. 8, p. 516, doi. 10.1093/jnci/djj129
- By:
- Publication type:
- Article
Efficacy of nilutamide as secondary hormonal therapy in androgen-independent prostate cancer.
- Published in:
- BJU International, 2005, v. 96, n. 6, p. 783, doi. 10.1111/j.1464-410X.2005.05714.x
- By:
- Publication type:
- Article
Clinical Review 134: The Endocrinology Of Prostate Cancer.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2001, v. 86, n. 8, p. 3467, doi. 10.1210/jcem.86.8.7782
- By:
- Publication type:
- Article